ByHeart
New York City, New York, United States
ByHeart is an American, vertically integrated infant formula company dedicated to innovating baby nutrition. They focus on owning the entire process from R&D to manufacturing, creating a breast milk-inspired formula with a patented protein blend using organic, grass-fed whole milk.
How We Help
Problem Statement
Existing infant formulas are not optimally designed or don't mimic breast milk closely enough, often containing undesirable ingredients, leading to a need for more innovative, higher-quality, and healthier alternatives for babies.
Core Technology
Patented breast milk-inspired infant formula featuring a unique protein blend (alpha-lactalbumin, lactoferrin, 80:20 whey to casein ratio) and organic, grass-fed whole milk, free from corn syrup, maltodextrin, soy, or palm oil.
Key Differentiators
Vertical integration, first new FDA-registered U.S. infant formula manufacturer in over 15 years, patented breast milk-inspired formula, use of organic grass-fed whole milk and certified-clean ingredients, extensive clinical trials, and the first U.S. infant formula to receive the Clean Label Project Purity Award.
Clinical Focus
Infant nutrition, supporting immune, cognitive, digestive, and microbiome health, with demonstrated benefits like easier digestion, less spit-up, and softer stools.
Target Customers
Parents and guardians of infants.
Product Stage
GA
Company Info
- Business Model
- B2C
- Founded
- 2016
- Total Funding
- 467,000,000
- Website
- byheart.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA-registered as the first new U.S. infant formula manufacturer in over 15 years. Conducted one of the largest clinical trials for a new infant formula brand in the U.S. in over 25 years, demonstrating clinically proven benefits such as easier digestion, less spit-up, and softer stools. Received the Clean Label Project Purity Award.
IP Protection
Patented protein blend for infant formula.
MedStartr Index Score
?What do you think of ByHeart?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.